Recall: Sodium Bicarbonate
Nov. 2022Pharmacy Updates
Exela Pharma Sciences LLC (Exela) has recalled 49 lots of Sodium Bicarbonate Injection, USP, 8.4%, 50 mEq/50 mL vial. This drug is used to treat a condition where there is too much acid in the body fluids. The product is packaged in a 50 mL glass vial. Read the full text of the Sodium Bicarbonate recall.
Recent Announcements
Access member care plans in UPMC Health Plan Tapestry Link
Starting Dec. 1, 2026, providers will be able to access SNP care plans within UPMC Health Plan Tapestry Link. Care plans are visible on a member’s chart in multiple locations:Nov. 2026Important Notices
UPMC Health Plan Tapestry Link resources available
UPMC Health Plan Tapestry Link will launch on Tuesday, Dec. 1, 2026. To help ease your transition to the new platform, we have developed the following resources:Nov. 2026Important Notices
Changes to inpatient denial and OBS claim billing
We will soon transition to the Epic® platform. This change will align our claims processing with industry standards by adjudicating claims based on the level of care authorized. As this transition approaches, please keep the following areas in mind:Nov. 2026